The Relationship Between Cardiac Troponin in People Hospitalised for Exacerbation of COPD and Major Adverse Cardiac Events (MACE) and COPD Readmissions

Constantinos Kallis,1– 3 Amit Kaura,1,3 Nathan A Samuel,4 Abdulrahim Mulla,3 Ben Glampson,3 Kevin O’Gallagher,5 Jim Davies,4 Dimitri Papadimitriou,3 Kerrie J Woods,4 Anoop D Shah,6,7 Bryan Williams,6,7 Folkert W Asselbergs,6,7 Erik K Mayer,3,8 Richard W Lee,1,9 Christopher Herbert,10 Stuart W Grant,...

Full description

Bibliographic Details
Published in:	International Journal of COPD
Main Authors:	Kallis C, Kaura A, Samuel NA, Mulla A, Glampson B, O'Gallagher K, Davies J, Papadimitriou D, Woods KJ, Shah AD, Williams B, Asselbergs FW, Mayer EK, Lee RW, Herbert C, Grant SW, Curzen N, Squire IB, Johnson T, Shah AM, Perera D, Kharbanda RK, Patel RS, Channon KM, Mayet J, Quint JK
Format:	Article
Language:	English
Published:	Dove Medical Press 2023-11-01
Subjects:	copd cvd exacerbation
Online Access:	https://www.dovepress.com/the-relationship-between-cardiac-troponin-in-people-hospitalised-for-e-peer-reviewed-fulltext-article-COPD

Similar Items

CLINICAL ROLE OF CARDIAC EXAMINATION IN COPD PATIENTS
by: E. G. Akramova
Published: (2012-02-01)

Systemic inflammation induced by exacerbation of COPD or pneumonia in patients with COPD induces cardiac troponin elevation
by: Tor-Arne Hagve, et al.
Published: (2021-01-01)

Impact of COPD and asthma on in-hospital mortality and management of patients with heart failure in England and Wales: an observational analysis
by: Claudia Gulea, et al.
Published: (2022-06-01)

Association between kidney function, frailty and receipt of invasive management after acute coronary syndrome
by: Richard Lee, et al.
Published: (2024-10-01)

Validity and interpretation of spirometric recordings to diagnose COPD in UK primary care
by: Rothnie KJ, et al.
Published: (2017-06-01)

Association of cardiovascular disease with COPD: cardiac function and structure evaluation
by: Sauwaluk Dacha, et al.
Published: (2022-11-01)

Pulmonary artery to aorta ratio is associated with cardiac structure and functional changes in mild-to-moderate COPD
by: Cuttica MJ, et al.
Published: (2017-05-01)

Phenogrouping heart failure with preserved or mildly reduced ejection fraction using electronic health record data
by: Fardad Soltani, et al.
Published: (2024-07-01)

Cardiac Dysfunction Indices and Their Prognostic Value in Acute Exacerbation COPD Patients
by: Ahmad B. Elden, et al.
Published: (2020-01-01)

Enhancing personalised care in COPD exacerbation: the role of cardiac/inflammatory biomarkers
by: Pouria Khashayar, et al.
Published: (2025-07-01)

Cardiac injury in patients with COPD presenting with dyspnea: a pilot study
by: Esosa Odigie-Okon, et al.
Published: (2010-11-01)

Diagnostic and prognostic value of an ejection fraction adjusted for myocardial remodeling
by: Wei Xuan Chan, et al.
Published: (2024-05-01)

Changes in the investigation and management of suspected myocardial infarction and injury during COVID-19: a multi-centre study using routinely collected healthcare data
by: Lara Chammas, et al.
Published: (2024-05-01)

Diagnostic and clinical values of non-cardiac ultrasound in COPD: A systematic review
by: Saeed M Alghamdi, et al.
Published: (2020-09-01)

Is COPD the Determinant Factor for Myocardial Injury and Cardiac Wall Stress in OSA Patients?
by: Athanasios Voulgaris, et al.
Published: (2023-10-01)

Systematic review and meta-analysis of prevalence of undiagnosed major cardiac comorbidities in COPD
by: Joseph Kibbler, et al.
Published: (2023-11-01)

Determinants of cardiac troponin T elevation in COPD exacerbation – a cross-sectional study
by: Smith Pål, et al.
Published: (2009-07-01)

Rational use of inhaled corticosteroids for the treatment of COPD
by: Jennifer K. Quint, et al.
Published: (2023-07-01)

Prognostic significance of troponin in patients with malignancy (NIHR Health Informatics Collaborative TROP-MALIGNANCY study)
by: Nathan A. Samuel, et al.
Published: (2024-07-01)

Changes in COPD inhaler prescriptions in the United Kingdom, 2000 to 2016
by: Bloom CI, et al.
Published: (2019-01-01)

K-MACE and Kernel K-MACE Clustering
by: Soosan Beheshti, et al.
Published: (2020-01-01)

Association of Race and Major Adverse Cardiac Events (MACE): The Atherosclerosis Risk in Communities (ARIC) Cohort
by: Ericha G Franey, et al.
Published: (2020-01-01)

Cardiac Biomarkers Predict Major Adverse Cardiac Events (MACE) in Incident Haemodialysis Patients: Results from a Global Federated Database
by: Elin Mitford Davies, et al.
Published: (2025-02-01)

Acute kidney injury in stable COPD and at exacerbation
by: Barakat MF, et al.
Published: (2015-09-01)

Cardiac Troponin I Levels in Acute Exacerbation of COPD Patients: A Cross-sectional Study
by: Anand Koppad, et al.
Published: (2023-01-01)

Pre-COPD: a New Advance in COPD
by: BAI Yahu, GAO Shenghan, JI Siyu, SHANG Jinyu, DONG Yanchun, NING Kang
Published: (2023-01-01)

Sarcopenia in COPD: relationship with COPD severity and prognosis
by: Tatiana Munhoz da Rocha Lemos Costa, et al.
Published: (2015-10-01)

National clinical audit for hospitalised exacerbations of COPD
by: John R. Hurst, et al.
Published: (2020-09-01)

Incidence and prevalence of asthma, COPD, and ILD across England, Wales, and South-East Scotland – a harmonised approach to data analysis
by: Sean Scully, et al.
Published: (2024-09-01)

Preventing adverse cardiac events (PACE) in chronic obstructive pulmonary disease (COPD): study protocol for a double-blind, placebo controlled, randomised controlled trial of bisoprolol in COPD
by: Graham S Hillis, et al.
Published: (2021-08-01)

Major Adverse Cardiovascular Events and Cause-Specific Mortality After Hospitalisation in COPD
by: Ioannides AE, et al.
Published: (2025-07-01)

Structured Cardiac Assessment and Treatment Following Exacerbations of COPD (SCATECOPD): A Pilot Randomised Controlled Trial
by: Joseph Kibbler, et al.
Published: (2025-03-01)

P73 THE ASSESSMENT OF PULMONARY ARTERY STIFFNESS IN COPD USING CARDIAC MRI THE Q/A METHOD
by: Nichola Gale, et al.
Published: (2017-12-01)

Assessment of Diastolic Dysfunction Parameters and Cardiac Chamber Size in Smokers with COPD: A Case Control Study
by: Vasudeva Acharya, et al.
Published: (2018-01-01)

HCKing COPD: unveiling the role of HCK in COPD pathogenesis
by: Richard Y. Kim, et al.
Published: (2025-05-01)

Unravelling young COPD and pre-COPD in the general population
by: Borja G. Cosío, et al.
Published: (2023-02-01)

Blurred lines. Eosinophilic COPD: ACOS or COPD phenotype?
by: C.C. Loureiro
Published: (2016-09-01)

Comorbidities and Cause of Death in COPD Patients Compared to Non-COPD Controls: An 8-year Observational Retrospective Healthcare Claims Database Cohort Study
by: Vogelmeier CF, et al.
Published: (2025-06-01)

Evaluation of Cytokine Levels in Cardiac Transthyretin and Immunoglobulin Light Chain Amyloidosis and Their Correlation with Myocardial Inflammatory Cells and MACE
by: Nicolas Musigk, et al.
Published: (2025-09-01)

Risk Factors Associated with a First Exacerbation Among Patients with COPD Classified as GOLD A and B in Routine Clinical Practice in the UK
by: Rothnie KJ, et al.
Published: (2023-11-01)